← All trials
NCT04742738
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 20, 2021
- Primary completion
- Jul 30, 2021
- Completion date
- Apr 30, 2022
- First posted
- Feb 8, 2021
- Last posted
- Oct 15, 2021
- Enrollment
- 260
- Arms / groups
- 7 / —
- Source
- AACT · ingestion pipeline
Sponsors
- SK Bioscience Co., Ltd.Lead sponsor
- Korea UniversityOverall official - principal investigator
- Coalition for Epidemic Preparedness InnovationsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.